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Abstract Purpose: Optimal strategies for reducing catheter-related blood stream infection (CR-BSI) differ for adults and children. National guidelines do not make child-specific recommendations. We determined whether evidence explained the inconsistencies between guidelines and reported practice in paediatric intensive care units (PICUs). Methods: We conducted a survey of eight interventions for reducing CR-BSI in all 25 British PICUs in 2009. Interventions were categorised as requiring child-specific evidence, generalisable to adults and children, or organisational recommendations. Results: Twenty-four of the 25 PICUs responded. For child-specific interventions, practice diverged from guidelines for ''Insert into subclavian/ jugular veins'' (18 PICUs frequently used femoral veins, supported by observational evidence for increased safety in children). Practice reflected guidelines for ''Use standard but consider antimicrobial-impregnated central venous catheters (CVCs) for high-risk patients'' (14 used standard only, 3 used standard and antimicrobial-impregnated despite no randomised controlled trial (RCT) evidence for antimicrobialimpregnated CVCs in children, 7 used heparin-bonded for some or all children); ''Use 2% chlorhexidine for skin preparation'' (20 PICUs); ''Avoid routine CVC replacement'' (20 PICUs). For generalisable interventions, practice was consistent with guidelines for ''Administration set replacement'' (21 PICUs) but deviated for ''Maintenance of CVC asepsis'' (11 PICUs used alcohol due to inconclusive evidence for chlorhexidine). Practice diverged from guidelines for organisational interventions: ''Train healthcare workers in CVC care'' (9 PICUs); ''Monitor blood stream infection (BSI) rates'' (8 PICUs) . Conclusions: Guidelines should explicitly address paediatric practice and report the quality of evidence and strength of recommendations. Organisations should ensure doctors are trained in CVC insertion and invest in BSI monitoring, especially in PICUs. The type of CVC and insertion site are important gaps in evidence for children.
Introduction
Central venous catheters (CVCs) are widely used in the UK National Health Service (NHS) with an estimated 238,000 inserted each year [1] . CVCs are associated with an increased risk of nosocomial blood stream infection (BSI), an important cause of mortality, morbidity, increased length of stay and substantial extra cost for paediatric patients [2] [3] [4] [5] [6] . An estimated 70% of nosocomial BSI in paediatric intensive care units (PICU) is caused by CVCs, with PICUs having the second highest rate of nosocomial BSI of all specialties (7.9 BSI per 1,000 patient-days) [7] .
Evidence from cohort studies and time series analyses shows that improving multiple elements of CVC insertion, access and maintenance can successfully reduce the rates of catheter-related BSI (CR-BSI) in PICUs [8] [9] [10] [11] . Maintenance care bundles have been found to be even more important than insertion care bundles for reducing CR-BSI in the paediatric setting [12] . Since 2005, campaigns to reduce the CR-BSI rate across all specialties have been launched in the UK, including the Department of Health's (DoH) Saving Lives care bundle based on the epic2 guidelines (national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England), and the Matching Michigan scheme (http://www.nrls.npsa.nhs.uk/ matchingmichigan/), based on a successful evidence-based intervention in Michigan ICUs [13] [14] [15] .
The DoH guidelines apply to all patients, whereas US guidelines recognise the specific considerations needed for the prevention of CR-BSI in children [16, 17] . For example, CVCs are more difficult to insert in children compared with adults due to smaller veins and they are often left in for longer periods of time due to difficulties in venous access [11] . In addition, the femoral vein is considered to be safer in children for emergency CVC insertion.
We hypothesised that divergence between national guidelines and reported practice in the UK might be explained by evidence specific to the paediatric setting. We selected eight interventions to reduce CR-BSI, and grouped interventions into those requiring paediatricspecific evidence, those where recommendations could be generalised across adult and paediatric populations, and non-clinical recommendations that require implementation at an organisational level.
Methods
We developed a 20-question survey about interventions to reduce CR-BSI and current CVC practice, including four open questions on factors impacting on infection control in PICUs and estimated rates of bacteraemia (available as ESM). The questionnaire was piloted on four clinicians prior to sending by email or post to a designated consultant at each of the 25 PICUs in the Paediatric Intensive Care Audit Network (PICANet) in Great Britain. Repeated requests were made to non-responders and responders with missing data. Responses were collected between January and October 2009.
We defined interventions that required child-specific evidence, according to the principles of the Cochrane Applicability and Recommendations Methods Group (http:// www.armg.cochrane.org), as those where physiological or technical reasons cause different benefits or harms, where different and identifiable factors may cause effect modification, or where clinically important differences in absolute risk exist, in children compared with adults. We classified four of the eight interventions as requiring child-specific evidence, two as being generalisable to children and adults, and two as organisational interventions requiring evidence comparing teams or hospitals (see Table 1 ). Categorisation was implemented post data collection.
For child-specific interventions, guidelines were classified as consistent with evidence if the guideline followed the best available evidence for children. All other guidelines were classified as consistent with evidence if the guideline followed the best available evidence. Consistency between reported practice and guidelines was categorised as (a) majority of PICUs reporting practice consistent with guidelines, (b) majority of PICUs reporting practice diverging from guidelines, or (c) majority of PICUs reporting practice diverging from guidelines but consistent with best available evidence. For intervention 2 (''Type of CVC''), we determined that practice was consistent with guidelines if PICUs followed the primary recommendation (use standard) or both the primary and secondary recommendations (use standard/ consider antimicrobial-impregnated).
The guidelines evaluated were those from the DoH Saving Lives care bundle and the epic2 guidelines. Guidelines were appraised by a search of all evidence referenced within their documentation [13, 14] . For childspecific interventions, we updated the reported searches by searching PubMed using search terms and synonyms for child, paediatric, intensive care and individual interventions. To evaluate the best available evidence underpinning guidelines, we classified studies into randomised controlled trials (RCTs) and observational studies. For the organisational interventions ''Training in CVC care'' and ''Monitor BSI rates'', RCTs may not be available and so we accepted observational evidence for these interventions. We evaluated the quality of all evidence using standard criteria for internal validity [18] .
Results
Responses were received from 24 of the 25 PICUs (96%). The majority of units estimated that 51-75% of emergency and 76-100% of post-operative admissions required a polyurethane CVC during their admission to PICU. Further results relating to each intervention are shown in Table 2 .
Thirteen PICUs reported a decline in nosocomial bacteraemia over the preceding 2 years. In response to being asked for any aspects of infection control considered to have had a significant impact on BSI in patients with a CVC, PICUs stated that factors contributing to declining infection rates included strict adherence to insertion asepsis, the introduction of CVC care bundles, use of 2% chlorhexidine, use of heparin-bonded or antibiotic-impregnated CVCs, nurse training, early removal of CVCs when not required, and auditing of hand-hygiene.
Discussion
National guidelines for reducing the risk of BSI are not child-specific, yet for certain recommendations, physiological or technical reasons mean that benefits or harms might differ in children compared with adults. For the four clinical interventions that required child-specific evidence, guidelines were supported by evidence of effectiveness, including safety in children, for only two of the interventions. Reported practice was consistent with guidelines for these two interventions. In contrast, lack of child-specific evidence on which to base guidelines explains why many PICUs choose to follow best available evidence contrary to guidelines for site of CVC insertion and type of CVC inserted. Without high-quality evidence supporting these guidelines, potential benefits or harms to children are uncertain. Reported practice also deviated from guidelines for one clinical intervention that did not require child-specific evidence but for which the evidence base was poor (swab hub with 2% chlorhexidine in alcohol prior to access).
Evidence from clinicians and research is needed to assess whether physiological or technical factors could lead to different benefits or harms, whether there is any evidence of effect modification of the interventions in children, and whether there are clinically important differences in the absolute risks of beneficial and/or harmful outcomes [43, 44] . Interventions based on high-quality evidence in adults should not automatically be recommended for children and guidelines should be clear about areas of uncertainty and very careful when extrapolating evidence from adults to children [45] .
Our findings emphasised the challenge in implementing evidence-based interventions at an organisational level, even where strong evidence already exists, such as for monitoring of BSI and staff training in CVC care [41] . Discrepancies between evidence and practice for these interventions may reflect the greater difficulties of overcoming system and organisational barriers to achieve evidence-based, institutional interventions compared with individual clinician or team-based decisions. Adoption of organisational interventions can be promoted by PICU clinicians but requires commitment from the top of the organisation and infrastructure. For example, establishing BSI surveillance could require considerable investment of staff time but measures of BSI both within and between units over time could be achieved through improving the feedback from the existing national surveillance system of BSI operated by the Health Protection Agency. This would overcome difficulties in obtaining consistent and meaningful measures for BSI rates across NHS PICUs [46] . This is the first survey conducted in the UK to assess variations in practice and adherence to multiple guidelines for reducing the risk of catheter-related infection in PICUs. The survey is limited in revealing only reported practice, although the Matching Michigan initiative may give a clearer picture of actual versus recommended practice in the future.
Our survey identified important areas of uncertainty and inconclusive evidence. Guidelines and reported practice in some PICUs diverged from best available evidence regarding the safety and effectiveness of heparin-bonded CVCs for reducing BSI. This question is currently being addressed by a large multi-centre RCT to determine the effectiveness of antibiotic-impregnated and heparin- Evidence: Strong RCT evidence of benefit for adults, weak RCT evidence of benefit for children and observational evidence of harm for preterm and very low birth weight babies 4
Practice for neonates was not separately recorded
Evidence for paediatric patients is lacking [28] . One RCT in neonates found chlorhexidine gluconate more effective than povidoneiodine in reducing CVC tip colonization in neonatal intensive care units (NICUs), and an observational study found chlorhexidine to be more effective than povidone-iodine in children on long-term haemodialysis [29, 30] . Cases of skin irritation have been reported with 2% chlorhexidine for preterm and very low birth weight neonates [31, 32] Research is needed to compare the risk of infection with CVC insertion at femoral, subclavian or internal jugular insertion sites, to investigate safety of chlorhexidine in neonates, and to assess the optimal time for catheter replacement. Hospitals should provide infrastructure to ensure training in optimal CVC care and monitoring of infection rates in PICUs as these require implementation at an organisational level or a change in hospital culture.
